Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study
<p>Abstract</p> <p>Background</p> <p>The transcription factor 7-like 2 (TCF7L2) is a critical component of the Wnt/β-catenin pathway. Aberrant <it>TCF7L2 </it>expression modifies Wnt signaling and mediates oncogenic effects through the upregulation of <it...
Main Authors: | Schmutzler Rita K, Meindl Alfons, Hemminki Kari, Shanmugam Kalai S, Burwinkel Barbara, Sutter Christian, Wappenschmidt Barbara, Kiechle Marion, Bartram Claus R, Frank Bernd |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-11-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/268 |
Similar Items
-
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
by: Bugert Peter, et al.
Published: (2007-05-01) -
Variants of transcription factor 7-like 2 (TCF7L2) gene and incident glucose intolerance in Japanese-Brazilians
by: L.F. Franco, et al.
Published: (2011-03-01) -
Variants of transcription factor 7-like 2 (TCF7L2) gene and incident glucose intolerance in Japanese-Brazilians
by: L.F. Franco, et al.
Published: (2011-03-01) -
Weak or no association of <it>TCF7L2 </it>variants with Type 2 diabetes risk in an Arab population
by: Al-Daghri Nasser, et al.
Published: (2008-07-01) -
Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes
by: Tanja Dujic, et al.
Published: (2019-05-01)